Brand Description
Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon
Key Personnel
NAME
JOB TITLE
-
CEO / President
-
EVP - CFO/Treasurer
-
Vice President, Manufacturing Sciences
-
SVP of Legal and Compliance and General Counsel
-
Vice President, Immunotherapy Sales and Customer Relations
-
VP, Clinical Development, Medical Affairs
-
VP
Yearly results
Sales: 214000
Headcount: 1,475
Bio/Pharma Revenues: $214 (346%)
Total Revenues: $342 (613%)
Royalty Revenues: $128 (n/a)
Net Income: $338
R&D Budget: $74 (-3%)
Top-Selling Drugs
| Drug | Indication | $ | (+/- %) |
| Provenge | prostate cancer | $214 | 346% |
Account for 100% of total biopharma sales, same as in 2010
